Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Medtronic
Dow
AstraZeneca
Express Scripts

Last Updated: July 1, 2022

CLINICAL TRIALS PROFILE FOR GALLIUM NITRATE


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Gallium Nitrate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00002543 ↗ Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors Completed National Cancer Institute (NCI) Phase 1 1995-02-01 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: : Phase I trial to study the effectiveness of gallium nitrate in young patients who have malignant brain tumors, neuroblastoma, rhabdomyosarcoma, non-Hodgkin's lymphoma, or refractory solid tumor.
NCT00002543 ↗ Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors Completed Medical College of Wisconsin Phase 1 1995-02-01 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: : Phase I trial to study the effectiveness of gallium nitrate in young patients who have malignant brain tumors, neuroblastoma, rhabdomyosarcoma, non-Hodgkin's lymphoma, or refractory solid tumor.
NCT00002578 ↗ Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma Completed National Cancer Institute (NCI) Phase 2 1994-08-01 RATIONALE: Chemotherapy uses different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of gallium nitrate in treating patients with AIDS-related non-Hodgkin's lymphoma.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Gallium Nitrate

Condition Name

Condition Name for Gallium Nitrate
Intervention Trials
Cystic Fibrosis 2
Lymphoma 2
Sarcoma 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Gallium Nitrate
Intervention Trials
Lymphoma 4
Fibrosis 3
Cystic Fibrosis 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Gallium Nitrate

Trials by Country

Trials by Country for Gallium Nitrate
Location Trials
United States 41
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Gallium Nitrate
Location Trials
Maryland 4
Washington 3
Colorado 2
Illinois 2
Iowa 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Gallium Nitrate

Clinical Trial Phase

Clinical Trial Phase for Gallium Nitrate
Clinical Trial Phase Trials
Phase 2 4
Phase 1 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Gallium Nitrate
Clinical Trial Phase Trials
Completed 5
Recruiting 1
Withdrawn 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Gallium Nitrate

Sponsor Name

Sponsor Name for Gallium Nitrate
Sponsor Trials
Cystic Fibrosis Foundation 3
National Cancer Institute (NCI) 2
Genta Incorporated 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Gallium Nitrate
Sponsor Trials
Other 11
NIH 2
Industry 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
Dow
Express Scripts
Baxter
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.